EMA issues guidance to curb microbial contamination in non-sterile medicines; MHRA reports record drug approvals
The European Medicines Agency has issued new guidance that outlines technical and organisational measures to reduce the risk of microbial contamination in non-sterile pharmaceutical products.
The document advises manufacturers on clean‑room design, environmental monitoring, personnel hygiene and validation procedures to help ensure product safety.
In related European regulatory news, the UK Medicines and Healthcare products Regulatory Agency highlighted in its 2025‑2026 annual report that it approved more new medicines than the previous year and removed a record number of illegal drugs from the market.
The MHRA also noted its intention to advance regulation of artificial intelligence in healthcare, reflecting a broader push to modernise oversight.
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Euro Roundup: EMA posts guidance on preventing microbial contamination of non-sterile products”
read at raps ↗
comments(0)
5-min edit window · permanent after that